logo-loader
viewEden Research plc

Eden Research gets 'emergency use' green light for Mevalone in France

Eden Research PLC's (LON:EDEN) Sean Smith tells Proactive London's Andrew Scott their fungicide, Mevalone, has been granted 120-day emergency use authorisation in France for the treatment of storage diseases on apples.

Smith says the emergency use approval represents the first authorisation for the use of Mevalone on apples and for the treatment of post-harvest storage diseases.

Quick facts: Eden Research plc

Price: 8.625 GBX

AIM:EDEN
Market: AIM
Market Cap: £17.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Eden Research plc named herein, including the promotion by the Company of Eden Research plc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Eden Research hails agreement with US giant Corteva

Biopesticides specialist Eden Research (LON:EDEN) has signed an exclusive evaluation agreement with Corteva Agriscience, an increasingly more significant global player in the use of greener seed technologies. Eden Research CEO Sean Smith tells Proactive London why the deal represents such a...

on 8/1/20

2 min read